Vanda Pharmaceuticals Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Vanda Pharmaceuticals Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Vanda Pharmaceuticals Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2024 was 58.3M shares, a 1.35% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 58.3M +776K +1.35% Oct 31, 2024 10-Q 2024-11-07
Q2 2024 58.3M +781K +1.36% Jul 25, 2024 10-Q 2024-08-01
Q1 2024 58.2M +754K +1.31% May 2, 2024 10-Q 2024-05-09
Q4 2023 57.5M +752K +1.33% Feb 1, 2024 10-K 2024-02-08
Q3 2023 57.5M +942K +1.67% Nov 2, 2023 10-Q 2023-11-09
Q2 2023 57.5M +947K +1.68% Jul 20, 2023 10-Q 2023-07-28
Q1 2023 57.4M +954K +1.69% Apr 27, 2023 10-Q 2023-05-03
Q4 2022 56.8M Feb 2, 2023 10-K 2023-02-09
Q3 2022 56.6M +878K +1.58% Oct 27, 2022 10-Q 2022-11-03
Q2 2022 56.6M +923K +1.66% Jul 28, 2022 10-Q 2022-08-04
Q1 2022 56.5M +925K +1.67% Apr 29, 2022 10-Q 2022-05-06
Q3 2021 55.7M +1.02M +1.87% Oct 28, 2021 10-Q 2021-11-04
Q2 2021 55.6M +987K +1.81% Jul 22, 2021 10-Q 2021-07-29
Q1 2021 55.6M +1.01M +1.86% Apr 29, 2021 10-Q 2021-05-06
Q4 2020 54.9M Feb 4, 2021 10-K 2021-02-11
Q3 2020 54.7M +1.35M +2.54% Oct 22, 2020 10-Q 2020-10-29
Q2 2020 54.7M +1.38M +2.59% Jul 30, 2020 10-Q 2020-08-06
Q1 2020 54.6M +1.59M +3% Apr 30, 2020 10-Q 2020-05-07
Q3 2019 53.3M +887K +1.69% Oct 31, 2019 10-Q 2019-11-07
Q2 2019 53.3M +894K +1.71% Jul 25, 2019 10-Q 2019-08-01
Q1 2019 53M +853K +1.64% Apr 24, 2019 10-Q 2019-05-03
Q4 2018 52.6M +7.2M +15.9% Feb 12, 2019 10-K 2019-02-19
Q3 2018 52.4M +7.52M +16.7% Oct 25, 2018 10-Q 2018-11-07
Q2 2018 52.4M +7.52M +16.8% Jul 19, 2018 10-Q 2018-08-02
Q1 2018 52.1M +7.56M +17% Apr 19, 2018 10-Q 2018-05-02
Q4 2017 45.4M +1.09M +2.46% Feb 1, 2018 10-K 2018-02-15
Q3 2017 44.9M +981K +2.23% Oct 30, 2017 10-Q 2017-11-08
Q2 2017 44.9M +1.57M +3.64% Jul 26, 2017 10-Q 2017-08-03
Q1 2017 44.6M +1.4M +3.24% Apr 24, 2017 10-Q 2017-05-03
Q4 2016 44.3M +1.24M +2.89% Feb 6, 2017 10-K 2017-02-17
Q3 2016 43.9M +1.13M +2.64% Oct 24, 2016 10-Q 2016-11-03
Q2 2016 43.3M +999K +2.36% Jul 21, 2016 10-Q 2016-07-28
Q1 2016 43.2M +1.51M +3.63% Apr 30, 2016 10-Q 2016-05-05
Q4 2015 43.1M Jan 31, 2016 10-K 2016-02-12
Q3 2015 42.8M +8.91M +26.3% Oct 30, 2015 10-Q 2015-11-04
Q2 2015 42.3M +8.41M +24.8% Jul 24, 2015 10-Q 2015-07-31
Q1 2015 41.6M +7.77M +22.9% Mar 6, 2015 10-K 2015-03-13
Q3 2014 33.9M +711K +2.14% Oct 22, 2014 10-Q 2014-10-27
Q2 2014 33.9M +5.39M +18.9% Jul 31, 2014 10-Q 2014-08-08
Q1 2014 33.9M +5.53M +19.5% Apr 30, 2014 10-Q 2014-05-08
Q3 2013 33.2M +4.96M +17.6% Oct 31, 2013 10-Q 2013-11-08
Q2 2013 28.5M +256K +0.91% Jul 26, 2013 10-Q 2013-07-31
Q1 2013 28.3M +120K +0.43% Apr 30, 2013 10-Q 2013-05-10
Q3 2012 28.2M +123K +0.44% Nov 5, 2012 10-Q 2012-11-08
Q2 2012 28.2M +123K +0.44% Jul 31, 2012 10-Q 2012-08-03
Q1 2012 28.2M Mar 7, 2012 10-K 2012-03-09
Q3 2011 28.1M Nov 2, 2011 10-Q 2011-11-07
Q2 2011 28.1M Aug 2, 2011 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.